Mkts

ACADIA Pharmaceuticals Inc.

NASDAQ: ACAD
$18.75+0.61 (+3.36%)
As of Nov 13, 4:00 PM ET

Key statistics

Day range
18.0018.76
52-week range
15.8630.96
Today
Open18.12
Previous close18.75
Volume—
Valuation
Market cap3.14B
P/E ratio8.66×
EPS (TTM)2.10
Income & risk
Dividend / yield—
Beta0.86
Avg volume2.02M
Discussion

ACAD News

Stories mentioning ACAD from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue268,062283,989278,633264,566244,317259,602250,401241,963
Cost of Goods Sold24,79126,22521,64720,73420,39221,80318,85718,230
Gross Profit243,271257,764256,986243,832223,925237,799231,544223,733
Operating Expenses
Research & Development76,86884,75787,82977,95178,265100,73166,60676,233
Sales General & Admin171,019155,616133,401133,507126,370130,080133,294117,063
Total Operating Expenses
Operating Income (Loss)(4,616)17,39135,75632,37419,290153,50331,64430,437
Interest Income
Interest Expense
Other Expense542.00596.00593.00594.00588.00575.00576.00386.00
Pretax Income3,98126,31944,59540,21127,779161,08538,80637,182
Tax Provision344.00(247,249)(27,184)13,5458,79217,3436,0413,793
Net Income (Loss)3,637273,56871,77926,66618,987143,74232,76533,389
Earnings Per Share (Basic)0.021.620.430.160.110.870.200.20
Earnings Per Share (Diluted)0.021.610.420.160.110.860.200.20
Weighted Average Shares Outstanding (Basic)170,517168,356168,836167,827166,808165,717165,974165,551
Weighted Average Shares Outstanding (Diluted)172,706169,919170,650168,681167,668166,362166,178166,174

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ACAD

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is a stock listed on the Nasdaq Stock Market under the ticker symbol ACAD. It last traded at $18.75 (Nov 13, 2026, 4:00 PM ET), up 3.4% on the day. That gives ACADIA Pharmaceuticals a market capitalisation of $3.1B and a price-to-earnings ratio of 8.7.

Over the past 52 weeks ACAD has traded between $15.86 and $30.96.

Revenue for the quarter ended Mar 31, 2026 was $268.1M; net income $3.6M. Revenue was up 9.7% from $244.3M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$268.1M$3.6M1.4%
Dec 31, 2025$284.0M$273.6M96.3%
Sep 30, 2025$278.6M$71.8M25.8%
Jun 30, 2025$264.6M$26.7M10.1%

From ACADIA Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…